FAU.de
Deutsch
Login
Home
Publications
Research Grants
Inventions & Patents
Awards
Additional Research Activities
Faculties & Institutions
Research Areas
Department of Medicine 1 – Gastroenterology, Pneumology and Endocrinology
Friedrich-Alexander-Universität Erlangen-Nürnberg
Medizinische Fakultät
Einrichtungen, die zum Universitätsklinikum Erlangen gehören
Overview
Publications
(1,569)
Research Grants
(74)
Types of publications
Toggle all
Journal article
Journal article
Book chapter / Article in edited volumes
Book chapter / Article in edited volumes
Authored book
Authored book
Translation
Translation
Thesis
Thesis
Edited Volume
Edited Volume
Conference contribution
Conference contribution
Other publication type
Other publication type
Unpublished / Preprint
Unpublished / Preprint
Publication year
From
To
Abstract
Journal
Filters (inactive)
The potential of omics technologies for the treatment of immune‐mediated inflammatory diseases (2021)
Anchang CG, Xu C, Raimondo MG, Atreya R, Maier A, Schett G, Zaburdaev V, et al.
Journal article, Review article
Target heterogeneity in oncology: The best predictor for differential response to radioligand therapy in neuroendocrine tumors and prostate cancer (2021)
Puranik AD, Dromain C, Fleshner N, Sathekge M, Pavel ME, Eberhardt N, Zengerling F, et al.
Journal article, Review article
Multicenter, Observational Study of Lanreotide Autogel for the Treatment of Patients with Neuroendocrine Tumors in Routine Clinical Practice in Germany and Austria (2021)
Rinke A, Maintz C, Muller L, Weber MM, Lahner H, Pavel ME, Saeger W, et al.
Journal article
Hepatobiliary malignancy surveillance strategies in primary sclerosing cholangitis associate with reduced mortality (2021)
Bergquist AM, Weismueller T, Levy C, Rupp C, Joshi D, Nayagam J, Montano-Loza AJ, et al.
Conference contribution
Implementation of a national registry for patients with primary biliary cholangitis (PBC): The German PBC cohort (2021)
Wiegand J, Stein K, Guenther R, Naumann U, Zimny S, Reuken P, Boettler T, et al.
Conference contribution
A randomized trial of a transglutaminase 2 inhibitor for celiac disease (2021)
Schuppan D, Mäki M, Lundin KE, Isola J, Friesing-Sosnik T, Taavela J, Popp A, et al.
Journal article
Epithelia-Sensory Neuron Cross Talk Underlies Cholestatic Itch Induced by Lysophosphatidylcholine (2021)
Chen Y, Wang ZL, Yeo M, Zhang QJ, López-Romero AE, Ding HP, Zhang X, et al.
Journal article
Treatment outcomes of advanced digestive well-differentiated grade 3 NETs (2021)
de Mestier L, Lamarca A, Hernando J, Zandee W, Alonso-Gordoa T, Perrier M, Walenkamp AM, et al.
Journal article
The Randomized AMBORA Trial: Impact of Pharmacological/Pharmaceutical Care on Medication Safety and Patient-Reported Outcomes During Treatment With New Oral Anticancer Agents (2021)
Dürr P, Schlichtig K, Kelz C, Deutsch B, Maas R, Eckart MJ, Wilke J, et al.
Journal article
Prebiotic Inulin and Sodium Butyrate Attenuate Obesity-Induced Intestinal Barrier Dysfunction by Induction of Antimicrobial Peptides (2021)
Beisner J, Filipe Rosa L, Kaden-Volynets V, Stolzer I, Günther C, Bischoff SC
Journal article
‹
1
...
49
50
51
52
53
...
157
›